Outcome of Schedule of Analyst/ Investor Meeting
3BBLACKBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
3B BlackBio Dx held a one-on-one meeting with Dalmus Capital Management (Mumbai) on December 20, 2025, lasting about an hour. The company clarified that no unpublished price-sensitive information was shared during the session. Management reiterated information already available in its Q2-FY26 Investor Presentation filed with the exchanges on November 13, 2025. The filing is a routine regulatory disclosure under SEBI LODR Regulation 30, with no new business or financial announcements.
No material impact on shareholders — this is a standard compliance filing confirming that nothing new was discussed beyond publicly available information. Stock price is unlikely to react.